tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jessica Tassan, 29 are a HOLD (26.85%), 3 are a SELL (2.78%), 76 are a BUY (70.37%).
Analyst Jessica Tassan, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 48.5% that have a potential upside of 12.94% achieved within 76 days.
Jessica Tassan’s has documented 225 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TDOC, Teladoc at 27-Feb-2025.
Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$12
$11.72 (4185.71%)
1 years 3 months 14 days ago
(17-Nov-2023)
0/1 (0%)
$4.37 (57.27%)
Hold
$0.5
$0.25 (100.00%)
$2.5
1 years 6 months 17 days ago
(14-Aug-2023)
0/5 (0%)
$3.12 (70.54%)
Buy
$0.8
$0.55 (220.00%)
$12
1 years 6 months 20 days ago
(11-Aug-2023)
0/3 (0%)
$3.48 (64.74%)
Buy
$17
1 years 6 months 20 days ago
(11-Aug-2023)
0/1 (0%)
$4.88 (40.26%)
Buy
1 years 11 months ago
(03-Apr-2023)
4/4 (100%)
$2.26 (47.68%)
338
Which stock is Jessica Tassan is most bullish on?
Which stock is Jessica Tassan is most reserved on?
What Year was the first public recommendation made by Jessica Tassan?
